237 related articles for article (PubMed ID: 35982125)
1. Subtype and cell type specific expression of lncRNAs provide insight into breast cancer.
Bjørklund SS; Aure MR; Häkkinen J; Vallon-Christersson J; Kumar S; Evensen KB; Fleischer T; Tost J; ; Sahlberg KK; Mathelier A; Bhanot G; Ganesan S; Tekpli X; Kristensen VN
Commun Biol; 2022 Aug; 5(1):834. PubMed ID: 35982125
[TBL] [Abstract][Full Text] [Related]
2. Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
Bradford JR; Cox A; Bernard P; Camp NJ
PLoS One; 2016; 11(9):e0163238. PubMed ID: 27685983
[TBL] [Abstract][Full Text] [Related]
3. LncRNAs exhibit subtype-specific expression, survival associations, and cancer-promoting effects in breast cancer.
Wasson MD; Venkatesh J; Cahill HF; McLean ME; Dean CA; Marcato P
Gene; 2024 Apr; 901():148165. PubMed ID: 38219875
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
[TBL] [Abstract][Full Text] [Related]
5. A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.
Cedro-Tanda A; Ríos-Romero M; Romero-Córdoba S; Cisneros-Villanueva M; Rebollar-Vega RG; Alfaro-Ruiz LA; Jiménez-Morales S; Domínguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Bautista-Piña V; Beltrán-Anaya FO; Hidalgo-Miranda A
Sci Rep; 2020 Aug; 10(1):13146. PubMed ID: 32753692
[TBL] [Abstract][Full Text] [Related]
6. Portraying breast cancers with long noncoding RNAs.
Van Grembergen O; Bizet M; de Bony EJ; Calonne E; Putmans P; Brohée S; Olsen C; Guo M; Bontempi G; Sotiriou C; Defrance M; Fuks F
Sci Adv; 2016 Sep; 2(9):e1600220. PubMed ID: 27617288
[TBL] [Abstract][Full Text] [Related]
7. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
8. Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
Ma X; Yu L; Wang P; Yang X
Comput Biol Chem; 2017 Aug; 69():164-170. PubMed ID: 28501295
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
10. The role of long non-coding RNAs in breast cancer microenvironment.
Yao W; Wang L; Liu F; Xia L
Pathol Res Pract; 2023 Aug; 248():154707. PubMed ID: 37506626
[TBL] [Abstract][Full Text] [Related]
11. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.
Wang L; Li J; Zhao H; Hu J; Ping Y; Li F; Lan Y; Xu C; Xiao Y; Li X
Mol Biosyst; 2016 Mar; 12(3):711-20. PubMed ID: 26725846
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
Su X; Malouf GG; Chen Y; Zhang J; Yao H; Valero V; Weinstein JN; Spano JP; Meric-Bernstam F; Khayat D; Esteva FJ
Oncotarget; 2014 Oct; 5(20):9864-76. PubMed ID: 25296969
[TBL] [Abstract][Full Text] [Related]
13. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs.
Li Y; Xu S; Xu D; Pan T; Guo J; Gu S; Lin Q; Li X; Li K; Xiang W
Front Immunol; 2022; 13():853904. PubMed ID: 35603200
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Cells Reprogram the Oncogenic lncRNAs/mRNAs Coexpression Networks in Three-Dimensional Microenvironment.
Nuñez-Olvera SI; Aguilar-Arnal L; Cisneros-Villanueva M; Hidalgo-Miranda A; Marchat LA; Salinas-Vera YM; Ramos-Payán R; Pérez-Plasencia C; Carlos-Reyes Á; Puente-Rivera J; López-Camarillo C
Cells; 2022 Nov; 11(21):. PubMed ID: 36359853
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression of lncRNA and miRNA subsets mediated by LRF during erythropoiesis.
Athanasopoulou K; Chondrou V; Xiropotamos P; Psarias G; Vasilopoulos Y; Georgakilas GK; Sgourou A
J Mol Med (Berl); 2023 Sep; 101(9):1097-1112. PubMed ID: 37486375
[TBL] [Abstract][Full Text] [Related]
17. Identifying lncRNA-mediated regulatory modules via ChIA-PET network analysis.
Thiel D; Conrad ND; Ntini E; Peschutter RX; Siebert H; Marsico A
BMC Bioinformatics; 2019 May; 20(1):292. PubMed ID: 31142264
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]